An alternative and conceptually new ‘pharmaco-metabonomic’ approach to personalizing drug treatment uses a combination of pre-dose metabolite profiling and chemometrics to model and predict the responses of individual subjects.
- T. Andrew Clayton
- John C. Lindon
- Jeremy K. Nicholson